PG
ALXN
Pendal Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-30,609
| Closed | -$5.62M | – | 672 |
|
|
2021
Q2 | $5.62M | Buy |
30,609
+26,100
| +579% | +$4.79M | 0.05% | 134 |
|
|
2021
Q1 | $689K | Buy |
4,509
+1,267
| +39% | +$194K | 0.01% | 365 |
|
|
2020
Q4 | $506K | Sell |
3,242
-42,911
| -93% | -$6.7M | 0.01% | 373 |
|
|
2020
Q3 | $5.28M | Sell |
46,153
-3,093
| -6% | -$354K | 0.06% | 97 |
|
|
2020
Q2 | $5.53M | Sell |
49,246
-3,283
| -6% | -$368K | 0.08% | 100 |
|
|
2020
Q1 | $4.72M | Sell |
52,529
-13,218
| -20% | -$1.19M | 0.08% | 92 |
|
|
2019
Q4 | $7.11M | Buy |
65,747
+64,212
| +4,183% | +$6.94M | 0.09% | 102 |
|
|
2019
Q3 | $150K | Buy |
+1,535
| New | +$150K | ﹤0.01% | 423 |
|
|
2018
Q1 | – | Sell |
-23,636
| Closed | -$2.83M | – | 509 |
|
|
2017
Q4 | $2.83M | Buy |
23,636
+22,461
| +1,912% | +$2.69M | 0.04% | 196 |
|
|
2017
Q3 | $165K | Buy |
+1,175
| New | +$165K | ﹤0.01% | 430 |
|